Shockwave Announces Updated Time for CAD III Investor Webcast Event in Conjunction with TCT Connect
October 01 2020 - 8:00AM
Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the
development and commercialization of Intravascular Lithotripsy
(IVL) to treat severely calcified cardiovascular disease, today
announced updated timing for the company’s CAD III Investor Webcast
Event to be held in conjunction with TCT Connect. The event will
now take place at 2:30 p.m. eastern
time on Thursday, October 15, 2020.
The webcast event will include a presentation of the DISRUPT CAD
III trial results by one of the study’s principal investigators as
well as a panel discussion and an interactive question and answer
session. Interested parties may access a live audio webcast of the
presentation by visiting the “Investors” section of the company’s
website at https://ir.shockwavemedical.com. A replay of the
webcast will be available following the presentation.
About Shockwave Medical,
Inc.
Shockwave is focused on developing and commercializing products
intended to transform the way calcified cardiovascular disease is
treated. Shockwave aims to establish a new standard of care for the
interventional treatment of atherosclerotic cardiovascular disease
through differentiated and proprietary local delivery of sonic
pressure waves for the treatment of calcified plaque, which the
company refers to as Intravascular Lithotripsy (IVL). IVL is a
minimally invasive, easy-to-use and safe way to significantly
improve patient outcomes. To view an animation of the IVL procedure
and for more information, visit www.shockwavemedical.com.
Media Contact: Scott Shadiow
+1.317.432.9210sshadiow@shockwavemedical.com
Investor Contact:Debbie Kasterdkaster@shockwavemedical.com
Shockwave Medical (NASDAQ:SWAV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Shockwave Medical (NASDAQ:SWAV)
Historical Stock Chart
From Apr 2023 to Apr 2024